1. Home
  2. CATO vs FLNA Comparison

CATO vs FLNA Comparison

Compare CATO & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

HOLD

Current Price

$3.19

Market Cap

58.0M

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.18

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CATO
FLNA
Founded
1946
1998
Country
United States
United States
Employees
N/A
20
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.0M
61.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CATO
FLNA
Price
$3.19
$1.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
72.9K
370.2K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
68.04
N/A
EPS
0.47
N/A
Revenue
$653,812,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.87
N/A
Revenue Growth
0.62
N/A
52 Week Low
$2.59
$1.16
52 Week High
$4.92
$2.03

Technical Indicators

Market Signals
Indicator
CATO
FLNA
Relative Strength Index (RSI) 50.84 36.04
Support Level $2.80 $1.16
Resistance Level $3.27 $1.80
Average True Range (ATR) 0.18 0.08
MACD -0.01 -0.01
Stochastic Oscillator 15.58 1.52

Price Performance

Historical Comparison
CATO
FLNA

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: